Analysis of signal transduction mechanism through a novel tyrosine kinase receptor

新型酪氨酸激酶受体信号转导机制分析

基本信息

  • 批准号:
    03454521
  • 负责人:
  • 金额:
    $ 3.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1991
  • 资助国家:
    日本
  • 起止时间:
    1991 至 1992
  • 项目状态:
    已结题

项目摘要

Previously, we cloned an ltk cDNA isolated from a human erythroleukemia cell line K562 cDNA library by low stringency hybridization with a c-fms probe. To obtain a full length cDNA, a cDNA library of human placenta was screened, and five positive clones were isolated. One clone (P2) contains the longest open reading frame which encodes a putative tyrosine kinase receptor of 864 amino acids. The analysis of the five clones revealed the existence of at least three spieces of cDNA clones. One cDNA predicts a protein of 221 amino acids and encodes a soluble type of receptor which can be secreted from the cell. Another cDNA clone (P3) has an alternative insert just downstream of the transmembrane domain and thus produce in-frame stop codon between the transmembrane domain and the tyrosine kinase domain, suggesting that this clone encodes a receptor protein lacking the kinase domain. We transfected expression plasmids containing various ltk cDNA clones to COS cells, and cell lysates were sub … More jected to western blot analysis. Proteins of approximately 100kD and 50kD were detected by the monoclonal antibody against the extracellular domain in the cell lysates transfected with P2 and P3, respectively. Both products are shown in double bands which may result from posttranslational modification. These results suggest that these cDNAs do not represent immature unspliced pre-mRNAs. Immune complexes from lysates of COS cells expressing the full ltk cDNA clone were subjected to in vitro kinase assay using [gamma-^<32>P]ATP. Phosphorylation of 100kD, 140kD, 85kD and 45kD proteins was detected in the experiment, suggesting that ltk protein has protein kinase activity and phosphorylates itself and other associated proteins. We have detected PLC-gamma1, GAP, PI3-kinase, and c-raf protein in the immune complex precipitated by anti-ltk antibody. In Northern blot analysis of 35 human malignancies, ltk is preferentially expressed in leukemias (10 out of 18 cases) with no cell lineage specificity, but none of 17 nonleukemic neoplasms expressed ltk gene. Less
在此之前,我们克隆了ltk的cDNA分离自人红白血病细胞系K562的cDNA文库的低严格杂交与c-fms探针。为获得全长cDNA,从人胎盘cDNA文库中筛选出5个阳性克隆。一个克隆(P2)含有最长的开放阅读框,其编码864个氨基酸的推定酪氨酸激酶受体。对这五个克隆的分析表明存在至少三个cDNA克隆。一个cDNA预测221个氨基酸的蛋白质,并编码可从细胞分泌的可溶性类型的受体。另一个cDNA克隆(P3)在跨膜结构域的下游具有替代插入物,因此在跨膜结构域和酪氨酸激酶结构域之间产生框内终止密码子,表明该克隆编码缺乏激酶结构域的受体蛋白。我们将含有不同ltk cDNA克隆的表达质粒转染COS细胞, ...更多信息 进行蛋白质印迹分析。P2和P3转染的细胞裂解液中,抗胞外区的单克隆抗体分别检测到约100 kD和50 kD的蛋白。两种产物均显示为双条带,可能是翻译后修饰所致。这些结果表明,这些cDNA不代表未成熟的未剪接的前mRNA。来自表达完整ltk cDNA克隆的COS细胞裂解物的免疫复合物使用[γ-β P]ATP进行体外激酶测定<32>。在实验中检测到100 kD、140 kD、85 kD和45 kD蛋白的磷酸化,表明ltk蛋白具有蛋白激酶活性,并磷酸化自身和其他相关蛋白。我们已经检测到PLC-γ 1,GAP,PI 3-激酶,和c-raf蛋白的免疫复合物沉淀的抗ltk抗体。北方印迹分析表明ltk基因在18例白血病中有10例优先表达,无细胞系特异性,而在17例非白血病肿瘤中均无ltk基因表达。少

项目成果

期刊论文数量(47)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hanazono Y, Chiba S, Sasaki K, Mano H, Miyajima A, Arai K, Yazaki Y, Hirai H.: "c-fpslfes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3." EMBO J.
Hanazono Y、Chiba S、Sasaki K、Mano H、Miyajima A、Arai K、Yazaki Y、Hirai H.:“c-fpslfes 蛋白酪氨酸激酶参与粒细胞巨噬细胞集落刺激因子和白细胞介素触发的信号通路
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chiba S,et al.: "Establishment and erythroid differentiation of a cytoーkineーdependent human leukemic cell line F36:A parental line requiring granulocyteーmacrophage colonyーstimulating factor or interleukin ー3,and a subline requiring erythropoietin." Blood.
Chiba S 等人:“细胞因子依赖性人白血病细胞系 F36 的建立和红系分化:需要细胞巨噬细胞集落刺激因子或白细胞介素 3 的亲本系,以及需要促红细胞生成素的亚系。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sugimoto K,et al.: "Frequent mutations in the p53 gene in human myeloid leukemia cell lines." Blood.
Sugimoto K 等人:“人骨髓性白血病细胞系中 p53 基因的频繁突变。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toyoshima H et al.: "Differently spliced cDNAs of human ltk receptor tyrosine leinase predict receptor proteins with and without tyrosine leinase sowain and a sdubli receptor protein." Proc.Nael.Acad.Sci.USA.
Toyoshima H 等人:“人类 ltk 受体酪氨酸酶的不同剪接 cDNA 可以预测有或没有酪氨酸酶 sowain 和 sdubli 受体蛋白的受体蛋白。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Hirai H, Ishikawa F, Takaku F.: "Mutations of the p53 gene in lymphoid leukemia." Blood. 77. 1153-1156 (1991)
Sugimoto K、Toyoshima H、Sakai R、Miyakawa K、Hagiwara K、Hirai H、Ishikawa F、Takaku F.:“淋巴细胞白血病中 p53 基因的突变。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIRAI Hisamaru其他文献

HIRAI Hisamaru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIRAI Hisamaru', 18)}}的其他基金

Analyses of Maltipotential Functions of a Novel Signaling Molecule, Cas
新型信号分子 Cas 的多电位功能分析
  • 批准号:
    11694250
  • 财政年份:
    1999
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Practical development of a novel method for hematopoietic stem cell expansion
造血干细胞扩增新方法的实际开发
  • 批准号:
    09357010
  • 财政年份:
    1997
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analyses of a Novel Signaling Molecule, Cas
新型信号分子 Cas 的分析
  • 批准号:
    09044271
  • 财政年份:
    1997
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Analysis of molecular mechanisms of leukemia development
白血病发生发展的分子机制分析
  • 批准号:
    09307021
  • 财政年份:
    1997
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of Molecular Mechanism of Blastic Crisis in Chronic Myelocytic Leukemia
慢性粒细胞白血病原始细胞危象的分子机制分析
  • 批准号:
    07042002
  • 财政年份:
    1995
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Functional analysis of AML1 gene in normal hematopoietic cells and leukemia cells
正常造血细胞和白血病细胞中AML1基因的功能分析
  • 批准号:
    07457229
  • 财政年份:
    1995
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular analysis of leukemias with chromosomal translocation and its application for clinical Diagnosis
染色体易位白血病的分子分析及其在临床诊断中的应用
  • 批准号:
    05454328
  • 财政年份:
    1993
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Molecular Diagnosis of Human Leukemias
人类白血病的分子诊断
  • 批准号:
    04253208
  • 财政年份:
    1992
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Development and clinical application of molecular diagnosis in leukemias
白血病分子诊断技术的发展及临床应用
  • 批准号:
    04557133
  • 财政年份:
    1992
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)

相似海外基金

CAREER: Tyrosine Phosphorylation and Kinase Activity as a Regulator of Sodium-Glucose Transporters
职业:酪氨酸磷酸化和激酶活性作为钠-葡萄糖转运蛋白的调节剂
  • 批准号:
    2340201
  • 财政年份:
    2024
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Continuing Grant
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
  • 批准号:
    10606132
  • 财政年份:
    2024
  • 资助金额:
    $ 3.9万
  • 项目类别:
Understanding the role of phosphorylation in RNA polymerase II transcription
了解磷酸化在 RNA 聚合酶 II 转录中的作用
  • 批准号:
    BB/Y004590/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Research Grant
Elucidation of physiological functions of Ulk1 phosphorylation which acts as a molecular switch leading to alternative autophagy
阐明 Ulk1 磷酸化的生理功能,其作为导致替代自噬的分子开关
  • 批准号:
    23K05748
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Functions and Regulation of Non-Proline Directed CDK1 Phosphorylation
研究非脯氨酸定向 CDK1 磷酸化的功能和调控
  • 批准号:
    BB/X007057/1
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Research Grant
Protein Phosphorylation Networks in Health and Disease
健康和疾病中的蛋白质磷酸化网络
  • 批准号:
    10682983
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
  • 批准号:
    10752404
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
How Serine-129 Phosphorylation Status Affects the Spreading of α-Synuclein Pathology in Vivo: a Study in Knock-in Animals
Serine-129 磷酸化状态如何影响体内 α-突触核蛋白病理学的传播:敲入动物研究
  • 批准号:
    10736995
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Delineating phosphorylation-mediated regulation of mitochondrial function
描绘磷酸化介导的线粒体功能调节
  • 批准号:
    10713378
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis
芯片磷酸化刺激突变运甲状腺素蛋白的降解以减轻心脏淀粉样变性
  • 批准号:
    10905158
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了